CMS(00867): The innovative drug phosphorus kitotinib cream has been approved for the Chinese market, becoming the first and only targeted therapy approved for the treatment of vitiligo in China.

12:14 30/01/2026

Kangze Pharmaceutical (00867) announced that its subsidiary Demai Pharmaceutical Co., Ltd. ("Demai Pharmaceutical"), an innovative pharmaceutical company specializing in skin health, is applying for independent listing on the main board of the Hong Kong Stock Exchange. On January 30, 2026, it obtained approval from the China National Medical Products Administration (NMPA) for the phosphorus luiketini cream (vitiligo indication) new drug application (NDA). The product is used to treat non-segmental vitiligo with facial involvement in children aged 12 and above and adult patients. It is the first and only targeted drug approved in China for the treatment of vitiligo, meeting a significant unmet clinical need.

CMS(00867) announced that its subsidiary, Demit Medical Limited ("Demit Medical"), a innovative pharmaceutical company specializing in skin health, is applying for an independent listing on the main board of the Hong Kong Stock Exchange. On January 30, 2026, Demit Medical obtained approval from the China National Medical Products Administration (NMPA) for its new drug application (NDA) for phosphatidylinositol-lysine-niacinamide phosphatidylcholine cream (indications for vitiligo). The product is for the treatment of non-segmental vitiligo in children aged 12 and above and adult patients with facial involvement. It is the first and only targeted drug approved in China for the treatment of vitiligo, meeting a huge unmet clinical need.

HK Stock Market Move | GigaDevice Semiconductor Inc. (03986) rose more than 4%, storage giant SanDisk's second-quarter performance exceeded expectations.

Shenwan Hongyuan Group: Maintains "buy" rating for EAST BUY (01797), optimizing product portfolio and significantly improving operational efficiency.

Zhongjin: Overseas emerging economies support the entry of aluminum demand into a new cycle, bullish on aluminum prices and the expansion of aluminum profit per ton.

HK Stock Market Move | GigaDevice Semiconductor Inc. (03986) rose more than 4%, storage giant SanDisk's second-quarter performance exceeded expectations.

Shenwan Hongyuan Group: Maintains "buy" rating for EAST BUY (01797), optimizing product portfolio and significantly improving operational efficiency.

Zhongjin: Overseas emerging economies support the entry of aluminum demand into a new cycle, bullish on aluminum prices and the expansion of aluminum profit per ton.